Recent discussions
-
Mayuki Aibiki
Dear friends:We are writing for your request of delivering JRC comments on CoSTR draft: antiarrhythmic drugs for cardiac arrest-adult. Please, kindly find our comments attached below.Hiroshi Nonogi, MD, PhD, FAHA, FJCC, FJCAToshikazu Funazaki MD, PhDMayuki Aibiki, MD, PhD Comment:The latest CoSTR draft has dealt with only RCTs including two Japanese studies of small number of OHCAs with shock-resistant VF. We are now raising recent systematic review (SR) including Japanese papers of non-RCTs describing the effects of nifekalant for OHCAs with refractory VF (ref.#3-7 as shown below). Total numbers of patients in such papers were 1532 in ref. #3-5; 317 in ref. #6.7. You should have already known that in the recent SR, there were no differences in ROSC, survival to admission, survival to discharge or neurological outcome in OHCA survivors between amiodarone and nifekalant; but in the comparisons between lidocaine and nifekalant, nifekalant demonstrated a significantly improved survival to admission (p=0.003), whereas no benefits in ROSC, survival to discharge or neurological outcomes. Reference1. Amino M, et al. Journal of cardiovascular pharmacology. 2010; 55: 391-8.2. Igarashi M, et al., Pacing Clin Electrophysiol. 2005;28 Suppl 1: S155-7.3. Harayama N, et al., J Anesth. 2014; 28: 587-92.4. Amino M, et. Al., Journal of cardiovascular pharmacology. 2015; 66: 600-9.5. Tagami T, et al., Resuscitation. 2016; 109: 127-132.6. Shiga T, et. al. Resuscitation. 2010; 81: 47-52.7. Tahara Y, et al., Circ J. 2006; 70: 442-6.8. Chowdhury A, et al., Heart Lung Circ. 2018; 27: 280-290. -
Saul Drajer
If amio and lido seem to be almost the same, we'll have to start looking for new drugs! Saul Drajer -
Kurt Anseeuw
Is there a difference in outcome in EMS systems where EMS-personnel is trained in using tracheal tube or supraglottic devices and EMS systems without these techniques ? -
Kurt Anseeuw
Nice work. Is there an effect of different dosing of antiarrhythmic drugs ? -
Jasmeet Soar
Thanks for the comments so far. The main change is that amiodarone and lidocaine have equal status in the treatment recommendation. Jasmeet Soar ALS TF Chair -
Jesús López Herce
Knowledge gapsThe quality of chest compression and ventilation was not evaluated in any study and these facts could significantly influence the results of CPR -
laurie morrison
Nicely done ALS And PLS TF and Heleen and Koen for the interface. -
Emily Montgomery
Does this represent a change from 2015 CoSTR? I don't think so. -
Jeroen Janssens
looking forward to see progress in the gaps. -
Joris Spruyt
well done